OmicsChart aims to advance precision oncology by unifying fragmented cancer data into an integrated ecosystem, enabling data-driven decisions in research and clinical care. Vedaly, a Cambridge-based scientific software and consulting company, supports translational research with data strategy, analytics, and collaborative platforms, where AI, data scientists, and research teams work together on real scientific evidence.